Boiron S.A.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more
Boiron S.A. (0DTF) - Net Assets
Latest net assets as of June 2025: €369.12 Million EUR
Based on the latest financial reports, Boiron S.A. (0DTF) has net assets worth €369.12 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€561.59 Million) and total liabilities (€192.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €369.12 Million |
| % of Total Assets | 65.73% |
| Annual Growth Rate | 5.15% |
| 5-Year Change | -25.73% |
| 10-Year Change | -9.1% |
| Growth Volatility | 14.76 |
Boiron S.A. - Net Assets Trend (2001–2024)
This chart illustrates how Boiron S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Boiron S.A. (2001–2024)
The table below shows the annual net assets of Boiron S.A. from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €378.18 Million | -3.40% |
| 2023-12-31 | €391.50 Million | -29.76% |
| 2022-12-31 | €557.35 Million | +4.81% |
| 2021-12-31 | €531.77 Million | +4.44% |
| 2020-12-31 | €509.17 Million | +0.73% |
| 2019-12-31 | €505.46 Million | +4.00% |
| 2018-12-31 | €486.04 Million | -6.08% |
| 2017-12-31 | €517.49 Million | +10.20% |
| 2016-12-31 | €469.60 Million | +12.87% |
| 2015-12-31 | €416.04 Million | +9.52% |
| 2014-12-31 | €379.88 Million | -3.06% |
| 2013-12-31 | €391.86 Million | +10.64% |
| 2012-12-31 | €354.16 Million | -3.93% |
| 2011-12-31 | €368.65 Million | +7.21% |
| 2010-12-31 | €343.84 Million | +9.76% |
| 2009-12-31 | €313.28 Million | +15.39% |
| 2008-12-31 | €271.49 Million | +8.62% |
| 2007-12-31 | €249.94 Million | +8.63% |
| 2006-12-31 | €230.09 Million | +0.09% |
| 2005-12-31 | €229.88 Million | +59.54% |
| 2004-12-31 | €144.09 Million | -3.64% |
| 2003-12-31 | €149.53 Million | +11.20% |
| 2002-12-31 | €134.47 Million | +12.84% |
| 2001-12-31 | €119.17 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Boiron S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 191.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €231.83 Million | 61.31% |
| Common Stock | €17.55 Million | 4.64% |
| Other Comprehensive Income | €56.29 Million | 14.89% |
| Other Components | €72.48 Million | 19.17% |
| Total Equity | €378.14 Million | 100.00% |
Boiron S.A. Competitors by Market Cap
The table below lists competitors of Boiron S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pasifik Donanım ve Yazılım Bilgi Tek As
IS:PATEK
|
$94.53 Million |
|
Shandong Kuntai New Material Technology Co. Ltd. A
SHE:001260
|
$94.55 Million |
|
Ultra Chip
TWO:3141
|
$94.60 Million |
|
Count Ltd
AU:CUP
|
$94.72 Million |
|
Son Ha International Corp
VN:SHI
|
$94.47 Million |
|
Klingon Aerospace Inc
TW:1529
|
$94.41 Million |
|
Carbios SAS
PINK:COOSF
|
$94.31 Million |
|
Bunker Hill Mining Corp
OTCQB:BHLL
|
$94.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Boiron S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 393,661,000 to 378,145,000, a change of -15,516,000 (-3.9%).
- Net income of 11,336,000 contributed positively to equity growth.
- Dividend payments of 23,439,000 reduced retained earnings.
- Share repurchases of 206,000 reduced equity.
- Other comprehensive income decreased equity by 14,767,000.
- Other factors increased equity by 11,560,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €11.34 Million | +3.0% |
| Dividends Paid | €23.44 Million | -6.2% |
| Share Repurchases | €206.00K | -0.05% |
| Other Comprehensive Income | €-14.77 Million | -3.91% |
| Other Changes | €11.56 Million | +3.06% |
| Total Change | €- | -3.94% |
Book Value vs Market Value Analysis
This analysis compares Boiron S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.11x to 1.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | €6.40 | €26.30 | x |
| 2002-12-31 | €7.23 | €26.30 | x |
| 2003-12-31 | €8.04 | €26.30 | x |
| 2004-12-31 | €7.74 | €26.30 | x |
| 2005-12-31 | €11.32 | €26.30 | x |
| 2006-12-31 | €10.50 | €26.30 | x |
| 2007-12-31 | €11.48 | €26.30 | x |
| 2008-12-31 | €12.46 | €26.30 | x |
| 2009-12-31 | €14.53 | €26.30 | x |
| 2010-12-31 | €16.01 | €26.30 | x |
| 2011-12-31 | €17.17 | €26.30 | x |
| 2012-12-31 | €16.63 | €26.30 | x |
| 2013-12-31 | €20.17 | €26.30 | x |
| 2014-12-31 | €19.70 | €26.30 | x |
| 2015-12-31 | €22.55 | €26.30 | x |
| 2016-12-31 | €25.48 | €26.30 | x |
| 2017-12-31 | €28.08 | €26.30 | x |
| 2018-12-31 | €27.32 | €26.30 | x |
| 2019-12-31 | €28.86 | €26.30 | x |
| 2020-12-31 | €29.08 | €26.30 | x |
| 2021-12-31 | €30.36 | €26.30 | x |
| 2022-12-31 | €32.07 | €26.30 | x |
| 2023-12-31 | €22.67 | €26.30 | x |
| 2024-12-31 | €21.78 | €26.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Boiron S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.33%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 1.52x
- Recent ROE (3.00%) is below the historical average (12.65%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 16.54% | 7.39% | 1.29x | 1.73x | €7.79 Million |
| 2002 | 17.13% | 8.02% | 1.24x | 1.72x | €9.58 Million |
| 2003 | 17.15% | 8.39% | 1.23x | 1.66x | €10.69 Million |
| 2004 | 14.30% | 7.09% | 1.07x | 1.88x | €6.19 Million |
| 2005 | 7.15% | 4.54% | 0.85x | 1.86x | €-6.55 Million |
| 2006 | 4.46% | 2.57% | 0.97x | 1.79x | €-12.75 Million |
| 2007 | 10.88% | 6.25% | 1.01x | 1.72x | €2.20 Million |
| 2008 | 14.45% | 8.39% | 1.01x | 1.71x | €12.07 Million |
| 2009 | 19.13% | 11.38% | 1.01x | 1.67x | €28.58 Million |
| 2010 | 12.60% | 8.31% | 0.93x | 1.62x | €8.92 Million |
| 2011 | 11.47% | 8.07% | 0.89x | 1.59x | €5.42 Million |
| 2012 | 14.02% | 8.76% | 0.98x | 1.64x | €14.23 Million |
| 2013 | 21.04% | 13.33% | 0.93x | 1.70x | €43.23 Million |
| 2014 | 23.45% | 14.60% | 0.91x | 1.76x | €51.08 Million |
| 2015 | 17.77% | 12.16% | 0.87x | 1.67x | €32.34 Million |
| 2016 | 16.55% | 12.65% | 0.81x | 1.61x | €30.77 Million |
| 2017 | 15.12% | 12.67% | 0.77x | 1.55x | €26.50 Million |
| 2018 | 11.82% | 9.51% | 0.79x | 1.58x | €8.86 Million |
| 2019 | 8.04% | 7.29% | 0.73x | 1.51x | €-9.92 Million |
| 2020 | 5.15% | 5.10% | 0.66x | 1.54x | €-24.70 Million |
| 2021 | 5.37% | 6.27% | 0.59x | 1.45x | €-24.62 Million |
| 2022 | 8.01% | 8.36% | 0.68x | 1.42x | €-11.09 Million |
| 2023 | 9.10% | 7.26% | 0.84x | 1.50x | €-3.54 Million |
| 2024 | 3.00% | 2.33% | 0.85x | 1.52x | €-26.48 Million |
Industry Comparison
This section compares Boiron S.A.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Boiron S.A. (0DTF) | €369.12 Million | 16.54% | 0.52x | $94.53 Million |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |